STOCK TITAN

[Form 4] Stryker Corporation Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4

Robert S. Fletcher, VP and Chief Legal Officer of Stryker Corporation (SYK), reported an insider sale on 08/20/2025. The Form 4 shows a disposition of 1,785 shares of Stryker common stock at a reported price of $393.07 per share. After the reported sale, Mr. Fletcher beneficially owned 10,457 shares directly and 162 shares indirectly through a 401(k) account. The filing was signed on 08/21/2025 by an attorney-in-fact for Mr. Fletcher. The form indicates this was an individual filing by one reporting person and does not list any derivative transactions.

Robert S. Fletcher, vicepresidente e Chief Legal Officer di Stryker Corporation (SYK), ha comunicato una vendita da parte di insider in data 20/08/2025. Il modulo 4 riporta la cessione di 1.785 azioni ordinarie Stryker a un prezzo dichiarato di 393,07 USD per azione. Dopo la vendita, il sig. Fletcher deteneva direttamente 10.457 azioni e 162 azioni indirettamente tramite un conto 401(k). La firma del documento è del 21/08/2025 ed è apposta da un procuratore che agisce per conto del sig. Fletcher. Il modulo indica che si tratta di una comunicazione individuale da parte di un unico soggetto segnalante e non riporta operazioni su strumenti derivati.

Robert S. Fletcher, vicepresidente y director jurídico (Chief Legal Officer) de Stryker Corporation (SYK), declaró una venta de insider el 20/08/2025. El Formulario 4 muestra la disposición de 1.785 acciones ordinarias de Stryker a un precio informado de 393,07 USD por acción. Tras la venta, el Sr. Fletcher poseía directamente 10.457 acciones y 162 acciones indirectamente a través de una cuenta 401(k). La presentación fue firmada el 21/08/2025 por un apoderado del Sr. Fletcher. El formulario indica que fue una declaración individual de una sola persona informante y no incluye transacciones con derivados.

로버트 S. 플레처(Robert S. Fletcher) 씨는 Stryker Corporation(SYK)의 부사장이자 최고법무책임자(VP 및 Chief Legal Officer)로서 2025년 8월 20일 내부자 매도를 신고했습니다. 제출된 Form 4에는 보통주 1,785주를 주당 393.07달러에 처분한 내역이 기재되어 있습니다. 보고된 매도 후 플레처 씨는 직접 10,457주를 보유하고 있으며 401(k) 계좌를 통해 간접적으로 162주를 보유하고 있었습니다. 서류는 2025년 8월 21일 플레처 씨를 대리하는 대리인(법률대리인)에 의해 서명되었습니다. 해당 양식은 단일 보고자에 의한 개인 신고임을 표시하며 파생상품 거래는 기재되어 있지 않습니다.

Robert S. Fletcher, vice-président et Chief Legal Officer de Stryker Corporation (SYK), a déclaré une vente d'initié le 20/08/2025. Le formulaire 4 indique la cession de 1 785 actions ordinaires Stryker à un prix déclaré de 393,07 USD par action. Après la vente signalée, M. Fletcher détenait directement 10 457 actions et 162 actions indirectement via un compte 401(k). Le dépôt a été signé le 21/08/2025 par un mandataire agissant pour le compte de M. Fletcher. Le formulaire précise qu'il s'agit d'une déclaration individuelle d'une seule personne déclarante et ne mentionne aucune transaction sur produits dérivés.

Robert S. Fletcher, VP und Chief Legal Officer der Stryker Corporation (SYK), meldete am 20.08.2025 einen Insider-Verkauf. Das Formular 4 weist die Veräußerung von 1.785 Aktien der Stammaktien von Stryker zu einem gemeldeten Preis von 393,07 USD je Aktie aus. Nach dem gemeldeten Verkauf hielt Herr Fletcher direkt 10.457 Aktien und indirekt 162 Aktien über ein 401(k)-Konto. Die Einreichung wurde am 21.08.2025 von einem Bevollmächtigten für Herrn Fletcher unterzeichnet. Das Formular gibt an, dass es sich um eine Einzelmeldung einer einzigen berichtspflichtigen Person handelt und listet keine Derivatgeschäfte auf.

Positive
  • None.
Negative
  • None.

Insights

TL;DR Routine officer sale of shares; ownership remains concentrated at modest levels, filing shows compliance with Section 16 reporting.

The reported sale of 1,785 shares at $393.07 appears as a straightforward Section 16 disclosure by an officer who also serves as a director. The remaining direct ownership of 10,457 shares and an indirect holding of 162 shares via a 401(k) are explicitly stated. There are no derivative positions disclosed and no indication of an amendment or reliance on a trading plan in the filing. The form is signed by an attorney-in-fact, which is common for administrative filings. From a governance perspective, the filing documents compliance with insider trading reporting requirements but does not, by itself, indicate a change in control or governance posture.

TL;DR Single-date disposition by an insider; transaction size is small relative to typical institutional holdings and presents limited market impact.

The sale on 08/20/2025 of 1,785 shares at $393.07 reduces the reporting person's direct stake to 10,457 shares. The filing lists no option exercise, no acquisitions, and no derivative activity. Given the absolute share counts disclosed, the transaction is a modest insider sale and likely not material to the company’s capitalization. This Form 4 furnishes required transparency on insider activity but contains no additional financial metrics or indications of company performance.

Robert S. Fletcher, vicepresidente e Chief Legal Officer di Stryker Corporation (SYK), ha comunicato una vendita da parte di insider in data 20/08/2025. Il modulo 4 riporta la cessione di 1.785 azioni ordinarie Stryker a un prezzo dichiarato di 393,07 USD per azione. Dopo la vendita, il sig. Fletcher deteneva direttamente 10.457 azioni e 162 azioni indirettamente tramite un conto 401(k). La firma del documento è del 21/08/2025 ed è apposta da un procuratore che agisce per conto del sig. Fletcher. Il modulo indica che si tratta di una comunicazione individuale da parte di un unico soggetto segnalante e non riporta operazioni su strumenti derivati.

Robert S. Fletcher, vicepresidente y director jurídico (Chief Legal Officer) de Stryker Corporation (SYK), declaró una venta de insider el 20/08/2025. El Formulario 4 muestra la disposición de 1.785 acciones ordinarias de Stryker a un precio informado de 393,07 USD por acción. Tras la venta, el Sr. Fletcher poseía directamente 10.457 acciones y 162 acciones indirectamente a través de una cuenta 401(k). La presentación fue firmada el 21/08/2025 por un apoderado del Sr. Fletcher. El formulario indica que fue una declaración individual de una sola persona informante y no incluye transacciones con derivados.

로버트 S. 플레처(Robert S. Fletcher) 씨는 Stryker Corporation(SYK)의 부사장이자 최고법무책임자(VP 및 Chief Legal Officer)로서 2025년 8월 20일 내부자 매도를 신고했습니다. 제출된 Form 4에는 보통주 1,785주를 주당 393.07달러에 처분한 내역이 기재되어 있습니다. 보고된 매도 후 플레처 씨는 직접 10,457주를 보유하고 있으며 401(k) 계좌를 통해 간접적으로 162주를 보유하고 있었습니다. 서류는 2025년 8월 21일 플레처 씨를 대리하는 대리인(법률대리인)에 의해 서명되었습니다. 해당 양식은 단일 보고자에 의한 개인 신고임을 표시하며 파생상품 거래는 기재되어 있지 않습니다.

Robert S. Fletcher, vice-président et Chief Legal Officer de Stryker Corporation (SYK), a déclaré une vente d'initié le 20/08/2025. Le formulaire 4 indique la cession de 1 785 actions ordinaires Stryker à un prix déclaré de 393,07 USD par action. Après la vente signalée, M. Fletcher détenait directement 10 457 actions et 162 actions indirectement via un compte 401(k). Le dépôt a été signé le 21/08/2025 par un mandataire agissant pour le compte de M. Fletcher. Le formulaire précise qu'il s'agit d'une déclaration individuelle d'une seule personne déclarante et ne mentionne aucune transaction sur produits dérivés.

Robert S. Fletcher, VP und Chief Legal Officer der Stryker Corporation (SYK), meldete am 20.08.2025 einen Insider-Verkauf. Das Formular 4 weist die Veräußerung von 1.785 Aktien der Stammaktien von Stryker zu einem gemeldeten Preis von 393,07 USD je Aktie aus. Nach dem gemeldeten Verkauf hielt Herr Fletcher direkt 10.457 Aktien und indirekt 162 Aktien über ein 401(k)-Konto. Die Einreichung wurde am 21.08.2025 von einem Bevollmächtigten für Herrn Fletcher unterzeichnet. Das Formular gibt an, dass es sich um eine Einzelmeldung einer einzigen berichtspflichtigen Person handelt und listet keine Derivatgeschäfte auf.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Fletcher Robert S

(Last) (First) (Middle)
1941 STRYKER WAY

(Street)
PORTAGE MI 49002

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
STRYKER CORP [ SYK ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
VP, Chief Legal Officer
3. Date of Earliest Transaction (Month/Day/Year)
08/20/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/20/2025 S 1,785 D $393.07 10,457 D
Common Stock 162 I 401(k)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Remarks:
/s/ Austin Y. Ke, attorney-in-fact for Robert S Fletcher 08/21/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Robert S. Fletcher (SYK) report on 08/20/2025?

The Form 4 reports a sale of 1,785 shares of Stryker common stock at $393.07 per share on 08/20/2025.

How many Stryker (SYK) shares did the reporting person own after the reported transaction?

After the sale, the reporting person beneficially owned 10,457 shares directly and 162 shares indirectly through a 401(k).

What is Robert S. Fletcher’s role at Stryker as listed on the Form 4?

The Form 4 lists Robert S. Fletcher as a Vice President and Chief Legal Officer; the filing also indicates Director status was checked.

Are there any derivative transactions or option exercises disclosed in this Form 4?

No. The filing shows no derivative securities acquired or disposed of; Table II lists no transactions.

Who signed the Form 4 and when was it signed?

The Form 4 was signed by Austin Y. Ke, attorney-in-fact for Robert S. Fletcher on 08/21/2025.
Stryker Corp

NYSE:SYK

SYK Rankings

SYK Latest News

SYK Latest SEC Filings

SYK Stock Data

141.08B
361.43M
5.36%
81.68%
1.09%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
PORTAGE